Showing results (351-360 of 443) with videos related to

Sort By:
Pageof 45
Hepatology Communications|January 24, 2023
Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCCAarti Kolluri, Dan Li, Nan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopesRonit Mazor, Jaime A Eberle, Xiaobo Hu, et al.
The Journal of Biological Chemistry|April 5, 2008
PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activityFiana Levitin, Mordechai Weiss, Yoonsoo Hahn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2015
Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factorSebastian Stahl, Ana Rita da Silva Mateus Seidl, Axel Ducret, et al.
Oncotarget|May 3, 2017
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesotheliomaShingo Inaguma, Zengfeng Wang, Jerzy Lasota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic AdenocarcinomaChristine Alewine, Mehwish Ahmad, Cody J Peer, et al.
The American Journal of Pathology|December 15, 2024
Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and ChallengesDan Li, Lalitya Andaloori, Matthew Crowe, et al.
International Journal of Cancer|February 11, 2012
Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cellNeetu Kalra, Jingli Zhang, Yunkai Yu, et al.
Immunology|January 14, 2023
Soluble programmed death ligand-1-induced immunosuppressive effects on chimeric antigen receptor-natural killer cells targeting Glypican-3 in hepatocellular carcinomaLin Chen, Siyuan Liu, Dickson Adah, et al.
Antibody Therapeutics|March 14, 2020
Isolation of rabbit single domain antibodies to B7-H3 via protein immunization and phage displayRuonan Feng, Ruixue Wang, Jessica Hong, et al.
Pageof 45